These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1357 related items for PubMed ID: 26535798

  • 1. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R, Lin G, Li J.
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [Abstract] [Full Text] [Related]

  • 2. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
    Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB, Bacchetta R, Tsalenko A, Dellinger D, Bruhn L, Porteus MH.
    Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
    [Abstract] [Full Text] [Related]

  • 3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V.
    AIDS Rev; 2017 Sep; 19(3):167-172. PubMed ID: 29019352
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S, Familghadakchi S, Motlagh RA, Farahani N, Dashtiahangar M, Rezaei H, Gheibi Hayat SM.
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [Abstract] [Full Text] [Related]

  • 9. Precision genome editing in the CRISPR era.
    Salsman J, Dellaire G.
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conditional Control of CRISPR/Cas9 Function.
    Zhou W, Deiters A.
    Angew Chem Int Ed Engl; 2016 Apr 25; 55(18):5394-9. PubMed ID: 26996256
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progress of application and off-target effects of CRISPR/Cas9.
    Zheng W, Gu F.
    Yi Chuan; 2015 Oct 25; 37(10):1003-10. PubMed ID: 26496752
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Target binding and residence: a new determinant of DNA double-strand break repair pathway choice in CRISPR/Cas9 genome editing.
    Feng Y, Liu S, Chen R, Xie A.
    J Zhejiang Univ Sci B; 2021 Jan 15; 22(1):73-86. PubMed ID: 33448189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.